Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics
NCT07519837Recruiting
- Sponsor
- China Medical University
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Trial (3 arms), sponsored by China Medical University. Primary endpoint: Skeletal muscle index at 12 months. Started Mar 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07519837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519837.